China Pharma Holdings, Inc. (CPHI): Gross Profit
-$131.9K
Year ended 2025-12-31
$460.2K
Trailing 12 months to 2026-06-30
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$131.9K | n/m | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | -$1.99M | n/m | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | -$281.1K | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$493.9K | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $349.3K | -82.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $1.95M | +31.8% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $1.48M | -24.9% | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | $1.97M | -20.0% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $2.47M | -23.3% | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | $3.22M | +119.8% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $1.46M | -45.1% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $2.67M | n/m | 2015-12-28, From 2014-01-01 |
| 2013-12-31 | -$480.9K | n/m | 2015-12-28, From 2013-01-01 |
| 2012-12-31 | $14.08M | -51.4% | 2014-03-20, From 2012-01-01 |
| 2011-12-31 | $28.99M | -4.3% | 2013-03-14, From 2011-01-01 |
| 2010-12-31 | $30.28M | n/a | 2012-03-14, From 2010-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$131.9K | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $1.38M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $6.38M | -72.2% |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $5.74M | -64.0% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $1.43M | +558.0% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $5.07M | -4.8% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $7.74M | -20.5% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $940.0K | n/a |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $11.60M | -25.0% |
Compare CPHI, PRPH, WHWK, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗